We are live on ! Find out more
KBC Group

KBC Group Portfolio holdings

AUM $39.9B
1-Year Est. Return 29.7%
This Fund
S&P 500
This Quarter Est. Return
-3.56%
1 Year Est. Return
+29.7%
3 Year Est. Return
+99.77%
5 Year Est. Return
+133.11%
10 Year Est. Return
+496.57%
AUM
$39.9B
AUM Growth
-$3.99B
Cap. Flow
-$1.18B
Cap. Flow %
-2.97%
Top 10 Hldgs %
37.22%
Holding
1,874
New
146
Increased
562
Reduced
366
Closed
20

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$543M
2
NVDA icon
NVIDIA
NVDA
+$373M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$178M
4
ABBV icon
AbbVie
ABBV
+$149M
5
MSFT icon
Microsoft
MSFT
+$146M

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$598M
2
NFLX icon
Netflix
NFLX
+$259M
3
JNJ icon
Johnson & Johnson
JNJ
+$239M
4
AMZN icon
Amazon
AMZN
+$217M
5
V icon
Visa
V
+$175M

Sector Composition

Rank Sector Weight
1 Technology 37.27%
2 Financials 12.41%
3 Healthcare 11.52%
4 Communication Services 10.2%
5 Industrials 8.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INVA icon
1626
Innoviva
INVA
$1.56B
$53K ﹤0.01%
2,260
– –
MGNI icon
1627
Magnite
MGNI
$2.57B
$53K ﹤0.01%
4,480
– –
SHO icon
1628
Sunstone Hotel Investors
SHO
$2.17B
$53K ﹤0.01%
5,844
– –
SPB icon
1629
Spectrum Brands
SPB
$2.01B
$53K ﹤0.01%
716
– –
AORT icon
1630
Artivion
AORT
$1.21B
$52K ﹤0.01%
1,417
– –
AZTA icon
1631
Azenta
AZTA
$1.3B
$52K ﹤0.01%
2,449
+1,238
+102% +$37K
BKE icon
1632
Buckle
BKE
$2.16B
$52K ﹤0.01%
1,024
– –
HRMY icon
1633
Harmony Biosciences
HRMY
$2.07B
$52K ﹤0.01%
1,844
– –
NKTR icon
1634
Nektar Therapeutics
NKTR
$2.34B
$52K ﹤0.01%
+721
New +$41.1K
TDOC icon
1635
Teladoc Health
TDOC
$1.56B
$52K ﹤0.01%
9,632
– –
TILE icon
1636
Interface
TILE
$1.9B
$52K ﹤0.01%
2,092
– –
VERA icon
1637
Vera Therapeutics
VERA
$2.61B
$52K ﹤0.01%
1,282
-670
-34% -$28.9K
WLY icon
1638
John Wiley & Sons Class A
WLY
$2.47B
$52K ﹤0.01%
1,361
– –
SOC icon
1639
Sable Offshore Corp
SOC
$893M
$52K ﹤0.01%
3,132
+1,026
+49% +$12K
DEI icon
1640
Douglas Emmett
DEI
$2.03B
$51K ﹤0.01%
5,398
– –
DXPE icon
1641
DXP Enterprises
DXPE
$2.71B
$51K ﹤0.01%
+364
New +$48.8K
HYMC icon
1642
Hycroft Mining Holding Corp
HYMC
$1.87B
$51K ﹤0.01%
+1,442
New +$55.8K
INTA icon
1643
Intapp
INTA
$2.02B
$51K ﹤0.01%
1,988
– –
LADR
1644
Ladder Capital
LADR
$1.22B
$51K ﹤0.01%
+5,264
New +$55.3K
NVTS icon
1645
Navitas Semiconductor
NVTS
$2.93B
$51K ﹤0.01%
+5,838
New +$53.8K
SLVM icon
1646
Sylvamo
SLVM
$1.49B
$51K ﹤0.01%
1,202
– –
WLDN icon
1647
Willdan Group
WLDN
$1.11B
$51K ﹤0.01%
667
– –
ABR icon
1648
Arbor Realty Trust
ABR
$966M
$50K ﹤0.01%
6,422
– –
CTS icon
1649
CTS Corp
CTS
$1.74B
$50K ﹤0.01%
1,055
– –
DCOM icon
1650
Dime Commercial Bancshares
DCOM
$1.73B
$50K ﹤0.01%
1,488
– –
64 65
66
67 68

Similar funds

HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
Mitsubishi UFJ Trust & Banking
Mitsubishi UFJ Trust & Banking Tokyo, Japan $40.6B AUM 25.18% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Newport Trust Company
Newport Trust Company Washington, District of Columbia $40.7B AUM 24.62% 1-Year Est. Return
CIBC Asset Management
CIBC Asset Management Toronto, Ontario, Canada $40.9B AUM 35.96% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

KBC Group's Q1 2026 Portfolio in Review

As of Q1 2026, KBC Group held 1,874 positions worth $39.9B, down 9.1% from $43.9B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

KBC Group's Q1 2026 filing shows 146 new, 562 increased, 366 reduced and 20 closed positions. Its largest new stake was AbbVie: 669,647 shares worth $146M. The largest sale was Alphabet (Google) Class C, an estimated $598M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 35% a quarter earlier, followed by Financials and Healthcare.

  • KBC Group's largest Q1 2026 buy was AbbVie: 669,647 shares worth $146M.
  • KBC Group added most to Apple in Q1 2026, an estimated $543M increase.
  • KBC Group's biggest Q1 2026 reduction was Alphabet (Google) Class C, cutting an estimated $598M.
  • KBC Group fully exited CyberArk in Q1 2026, selling an estimated $6.81M.
  • KBC Group's ten largest holdings make up 37% of its $39.9B portfolio in Q1 2026.
  • KBC Group opened 146 new positions and closed 20 in Q1 2026.
  • KBC Group's portfolio value fell 9.1% quarter-over-quarter to $39.9B.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.